- Home
- AUPH vs BST Comparison
AUPH vs BST Comparison
Compare AUPH & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- BST
- Stock Information
- Founded
- AUPH 1993
- BST 2014
- Country
- AUPH Canada
- BST United States
- Employees
- AUPH N/A
- BST N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- BST Finance Companies
- Sector
- AUPH Health Care
- BST Finance
- Exchange
- AUPH Nasdaq
- BST Nasdaq
- Market Cap
- AUPH 1.4B
- BST 1.4B
- IPO Year
- AUPH 1999
- BST N/A
- Fundamental
- Price
- AUPH $12.22
- BST $40.42
- Analyst Decision
- AUPH Strong Buy
- BST
- Analyst Count
- AUPH 4
- BST 0
- Target Price
- AUPH $12.25
- BST N/A
- AVG Volume (30 Days)
- AUPH 1.7M
- BST 88.4K
- Earning Date
- AUPH 11-06-2025
- BST 01-01-0001
- Dividend Yield
- AUPH N/A
- BST 7.42%
- EPS Growth
- AUPH N/A
- BST N/A
- EPS
- AUPH 0.42
- BST N/A
- Revenue
- AUPH $260,111,000.00
- BST N/A
- Revenue This Year
- AUPH $16.92
- BST N/A
- Revenue Next Year
- AUPH $14.29
- BST N/A
- P/E Ratio
- AUPH $29.10
- BST N/A
- Revenue Growth
- AUPH 25.59
- BST N/A
- 52 Week Low
- AUPH $6.42
- BST $27.87
- 52 Week High
- AUPH $12.82
- BST $40.56
- Technical
- Relative Strength Index (RSI)
- AUPH 61.79
- BST 64.82
- Support Level
- AUPH $11.57
- BST $38.16
- Resistance Level
- AUPH $12.82
- BST $40.24
- Average True Range (ATR)
- AUPH 0.36
- BST 0.47
- MACD
- AUPH -0.10
- BST 0.05
- Stochastic Oscillator
- AUPH 52.08
- BST 93.78
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.